Discover how CD9 upregulation in ovarian cancer drives TNF-α expression and constitutive NF-κB activation, creating a powerful survival mechanism for cancer cells.
Explore how nanotechnology is revolutionizing ovarian cancer treatment through targeted drug delivery systems that improve efficacy while reducing side effects.
Explore how bispecific antibodies are transforming ovarian cancer treatment by bridging immune cells directly to cancer cells for targeted destruction.
Explore how electroporation technology is transforming ovarian cancer treatment by overcoming drug resistance through electrical pulses.
Discover how scientists isolate VEGF from ovarian cancer ascitic fluid to develop targeted cancer therapies.
Exploring how GDF-15 protein serves as both biomarker and active driver in epithelial ovarian cancer progression and treatment resistance